Home › Funds › Temasek Holdings › DNLI
Temasek Holdings position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)7.01M sh
Reported value held$180.37M
Portfolio Weight0.51%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 5.37M | $270.89M | New |
| Q4 2021 | 5.37M | $239.48M | Hold |
| Q1 2022 | 5.37M | $172.74M | Hold |
| Q2 2022 | 5.37M | $158.02M | Hold |
| Q3 2022 | 5.58M | $171.13M | Add |
| Q4 2022 | 6.52M | $181.21M | Add |
| Q1 2023 | 6.90M | $158.88M | Add |
| Q2 2023 | 6.90M | $203.50M | Hold |
| Q3 2023 | 6.90M | $142.26M | Hold |
| Q4 2023 | 6.90M | $147.99M | Hold |
| Q1 2024 | 5.71M | $117.09M | Reduce |
| Q2 2024 | 5.71M | $132.50M | Hold |
| Q3 2024 | 5.36M | $156.02M | Reduce |
| Q4 2024 | 5.36M | $109.15M | Hold |
| Q1 2025 | 5.36M | $72.81M | Hold |
| Q1 2025 | 5.36M | $72.81M | Hold |
| Q2 2025 | 5.36M | $74.93M | Hold |
| Q2 2025 | 5.36M | $74.93M | Hold |
| Q3 2025 | 5.36M | $77.77M | Hold |
| Q4 2025 | 7.01M | $115.78M | Add |
| Q1 2026 | 7.01M | $134.65M | Hold |
| Q2 2026 | 7.01M | $180.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026